ABBV vs. AMD: AbbVie vs. Advanced Micro Devices Stock Comparison
How do AbbVie (ABBV) and Advanced Micro Devices (AMD) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
AbbVie (ABBV) is classified in the Health Care sector (Pharmaceuticals, Biotechnology & Life Sciences), whereas Advanced Micro Devices (AMD) belongs to Information Technology (Semiconductors & Semiconductor Equipment) — their GICS classifications point to very different parts of the market.
| Profile Item | ABBV | AMD |
|---|---|---|
| Name | AbbVie Inc. | Advanced Micro Devices Inc. |
| Country/Region | United States | United States |
| GICS Sector | Health Care | Information Technology |
| GICS Industry Group | Pharmaceuticals, Biotechnology & Life Sciences | Semiconductors & Semiconductor Equipment |
| GICS Industry | Biotechnology | Semiconductors & Semiconductor Equipment |
| GICS Sub-Industry | Biotechnology | Semiconductors |
| Market Capitalization | 514.92 billion USD | 736.46 billion USD |
| Currency | USD | USD |
| Exchange | NYSE | Nasdaq |
| Listing Date | January 2, 2013 | March 17, 1980 |
| Security Type | Common Stock | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | ABBV | AMD |
|---|---|---|
| Total Return (1Y) | 37.33% | 114.18% |
| Total Return (3Y, Annualized) | 32.74% | 63.95% |
| Total Return (5Y, Annualized) | 24.73% | 27.42% |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
Advanced Micro Devices (AMD) has a highly aggressive beta of 2.53, indicating much higher sensitivity to broad-market moves, while AbbVie (ABBV) is defensive at 0.21 and tends to be less market-sensitive — a wide gap in beta profiles.
| Metric | ABBV | AMD |
|---|---|---|
| Volatility (1Y, Annualized) | 25.65% | 72.86% |
| Beta (5Y) | 0.21 | 2.53 |
| Max Drawdown (5Y) | -21.92% | -65.45% |
| Avg. Volume (3M) | 4.76M | 22.40M |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | ABBV | AMD |
|---|---|---|
| Sharpe Ratio (1Y) | 1.29 | 1.51 |
| Sortino Ratio (1Y) | 2.02 | 2.32 |
Profitability
ROE (TTM)
Capital efficiency shows on one side only: Advanced Micro Devices (AMD) earns 11.96% on shareholders’ equity, ranked against its industry; AbbVie (ABBV) has no ROE this period.
ABBV
Pharmaceuticals, Biotechnology & Life Sciences industry group
--
- Max
- 109.18%
- Q3
- 6.23%
- Median
- -26.66%
- Q1
- -64.05%
- Min
- -167.77%
- ABBV
- --
AMD
Semiconductors & Semiconductor Equipment industry group
11.96%
- Max
- 52.82%
- Q3
- 22.26%
- AMD
- 11.96%
- Median
- 10.58%
- Q1
- 1.29%
- Min
- -16.89%
Net Margin (TTM)
AbbVie (ABBV) at 15.67% retains a top-quartile share of revenue as profit, ahead of Advanced Micro Devices (AMD) at 16.77%, which keeps about the industry-typical share.
ABBV
Pharmaceuticals, Biotechnology & Life Sciences industry group
15.67%
- Max
- 18.05%
- ABBV
- 15.67%
- Q3
- 4.78%
- Median
- 0.00%
- Q1
- -4.14%
- Min
- -17.05%
AMD
Semiconductors & Semiconductor Equipment industry group
16.77%
- Max
- 63.80%
- Q3
- 28.36%
- AMD
- 16.77%
- Median
- 11.44%
- Q1
- 0.90%
- Min
- -37.77%
Operating Margin (TTM)
AbbVie (ABBV) at 39.59% operates in the top operating margin quartile, ahead of Advanced Micro Devices (AMD) at 21.17%, which runs around its industry’s norm.
ABBV
Pharmaceuticals, Biotechnology & Life Sciences industry group
39.59%
- Max
- 83.12%
- ABBV
- 39.59%
- Q3
- 14.77%
- Median
- 0.00%
- Q1
- -78.82%
- Min
- -207.40%
AMD
Semiconductors & Semiconductor Equipment industry group
21.17%
- Max
- 58.66%
- Q3
- 30.23%
- AMD
- 21.17%
- Median
- 15.91%
- Q1
- 7.54%
- Min
- -25.74%
Profitability Metrics
| Metric | ABBV | AMD |
|---|---|---|
| ROE (TTM) | -- | 11.96% |
| ROA (TTM) | 10.74% | 5.90% |
| Net Margin (TTM) | 15.67% | 16.77% |
| Operating Margin (TTM) | 39.59% | 21.17% |
| Gross Margin (TTM) | 73.72% | 56.00% |
Growth
Revenue Growth
Advanced Micro Devices (AMD) at 34.34% sits in the top revenue growth quartile, while AbbVie (ABBV) at 8.57% is closer to the peer norm — faster top-line expansion for AMD.
EPS Growth
Advanced Micro Devices (AMD) at 165.00% clears its industry range for EPS growth, a much stronger earnings trajectory than AbbVie (ABBV) at -0.84%, which is closer to a typical peer reading.
Growth Metrics
| Metric | ABBV | AMD |
|---|---|---|
| Revenue Growth (YoY) | 8.57% | 34.34% |
| Revenue Growth (3Y CAGR) | 1.75% | 13.64% |
| EPS Growth (YoY) | -0.84% | 165.00% |
| EPS Growth (3Y CAGR) | -29.03% | 46.66% |
Financial Strength
Current Ratio (MRQ)
Advanced Micro Devices (AMD) at 2.73 keeps current ratio within its industry’s typical mid-range, while AbbVie (ABBV) at 0.87 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for ABBV.
ABBV
Pharmaceuticals, Biotechnology & Life Sciences industry group
0.87
- Max
- 25.13
- Q3
- 12.13
- Median
- 5.52
- Q1
- 2.47
- ABBV
- 0.87
- Min
- 0.10
AMD
Semiconductors & Semiconductor Equipment industry group
2.73
- Max
- 10.33
- Q3
- 5.62
- Median
- 3.33
- AMD
- 2.73
- Q1
- 2.35
- Min
- 1.03
Debt / Equity (MRQ)
Only one side’s leverage can be read here: Advanced Micro Devices (AMD) carries debt-to-equity ratio of 0.13 against its industry range, while AbbVie (ABBV) reports no figure this period.
ABBV
Pharmaceuticals, Biotechnology & Life Sciences industry group
--
- Max
- 1.42
- Q3
- 0.65
- Median
- 0.15
- Q1
- 0.02
- Min
- 0.00
- ABBV
- --
AMD
Semiconductors & Semiconductor Equipment industry group
0.13
- Max
- 1.46
- Q3
- 0.65
- Median
- 0.27
- AMD
- 0.13
- Q1
- 0.04
- Min
- 0.00
Financial Strength Metrics
| Metric | ABBV | AMD |
|---|---|---|
| Current Ratio (MRQ) | 0.87 | 2.73 |
| Debt / Equity (MRQ) | -- | 0.13 |
| Net Debt / EBITDA | 2.21 | -0.59 |
Dividends
Dividend Yield (TTM)
Advanced Micro Devices (AMD) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile AbbVie (ABBV) reports a yield of 2.40%, ranking against industry peers normally.
ABBV
Pharmaceuticals, Biotechnology & Life Sciences industry group
2.40%
- ABBV
- 2.40%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
AMD
Semiconductors & Semiconductor Equipment industry group
0.00%
- Max
- 1.37%
- Q3
- 0.65%
- AMD
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
AbbVie (ABBV) reports payout ratio above 100% at 117.35%, meaning dividends exceeded current-period earnings; Advanced Micro Devices (AMD) pays no dividend (payout 0.00%).
ABBV
Pharmaceuticals, Biotechnology & Life Sciences industry group
117.35%
- ABBV
- 117.35%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
AMD
Semiconductors & Semiconductor Equipment industry group
0.00%
- Max
- 49.64%
- Q3
- 21.71%
- AMD
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | ABBV | AMD |
|---|---|---|
| Dividend Yield (TTM) | 2.40% | 0.00% |
| Dividend Payout Ratio (TTM) | 117.35% | 0.00% |
Valuation
P/E Ratio (TTM)
Both AbbVie (ABBV) at 50.05 and Advanced Micro Devices (AMD) at 95.95 sit in the richer earnings-multiple quartile for P/E ratio, so investors are paying more for TTM earnings than they pay for typical peers.
ABBV
Pharmaceuticals, Biotechnology & Life Sciences industry group
50.05
- Max
- 85.34
- ABBV
- 50.05
- Q3
- 43.46
- Median
- 26.69
- Q1
- 13.30
- Min
- 0.07
AMD
Semiconductors & Semiconductor Equipment industry group
95.95
- Max
- 110.34
- AMD
- 95.95
- Q3
- 66.81
- Median
- 37.02
- Q1
- 23.96
- Min
- 8.12
P/S Ratio (TTM)
AbbVie (ABBV) at 7.80 is priced about in line with its industry on P/S ratio, while Advanced Micro Devices (AMD) at 16.21 sits in the pricier quartile — AMD costs more per dollar of sales.
ABBV
Pharmaceuticals, Biotechnology & Life Sciences industry group
7.80
- Max
- 58.18
- Q3
- 25.77
- ABBV
- 7.80
- Median
- 7.30
- Q1
- 3.01
- Min
- 0.01
AMD
Semiconductors & Semiconductor Equipment industry group
16.21
- Max
- 21.42
- AMD
- 16.21
- Q3
- 12.27
- Median
- 5.76
- Q1
- 2.73
- Min
- 0.00
P/B Ratio (MRQ)
AbbVie (ABBV) reports a negative P/B ratio of -112.34, meaning negative book equity — the multiple itself is not meaningful for valuation. Meanwhile Advanced Micro Devices (AMD) reports 10.77, ranking against industry peers normally.
ABBV
Pharmaceuticals, Biotechnology & Life Sciences industry group
-112.34
- Max
- 13.53
- Q3
- 6.54
- Median
- 3.25
- Q1
- 1.69
- Min
- -5.59
- ABBV
- -112.34
AMD
Semiconductors & Semiconductor Equipment industry group
10.77
- Max
- 14.06
- AMD
- 10.77
- Q3
- 7.44
- Median
- 4.29
- Q1
- 2.30
- Min
- 0.20
Valuation Metrics
| Metric | ABBV | AMD |
|---|---|---|
| P/E Ratio (TTM) | 50.05 | 95.95 |
| P/S Ratio (TTM) | 7.80 | 16.21 |
| P/B Ratio (MRQ) | -112.34 | 10.77 |
| Free Cash Flow Yield (TTM) | 3.44% | 1.00% |